​​CancerVacs Inc


About Us

IntraLymphNode ImmunoTherapeutics for Metastatic Cancer Patients

CancerVacs Inc


CancerVacs Inc

CancerVacs product candidates activate patients’ anti-tumor immunity in vivo by administering low doses of anti-cancer antigens, including cancer testis antigen epitopes, monoclonal antibodies, dendritic cells and cytokine therapeutics directly into metastatic cancer patients’ lymph nodes. Intralymphnode immunotherapeutic products enable patients with disseminated tumors to generate long term clinical immune responses to their own tumors. Currently, there is no effective treatment or cure for disseminated follicular lymphoma and certain metastatic solid cancers, including melanomas, carcinomas, and gliomas.